» Articles » PMID: 22827273

Recurrence Risk Factors in Patients with the Vogt-Koyanagi-Harada Syndrome in Japan

Overview
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2012 Jul 26
PMID 22827273
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The Vogt-Koyanagi-Harada (VKH) syndrome is a form of recurrent uveitis with often a poor long-term visual acuity. The risk factors for recurrence of the VKH syndrome were investigated statistically by using a multiple logistic regression model. The clinical data of 87 patients were used for the statistical analysis. Among them, 58 patients (66.8%) had no recurrences, while 29 patients (33.3%) had recurrences. By multiple logistic regression analysis, dysacousia (p<0.01), cutaneous manifestations (p<0. 05), prodromal symptoms (p<0. 05), onset to treatment interval (days) (p<0. 05) and retinal detachment (p<0. 01) were significantly and independently associated with the recurrence. The Relapse Score was constructed by using a logistic model as follows: Relapse Score=+1. 459X (Dysacousia) + 1. 458x (Cutaneous manifestations) +0. 032x (Onset to treatment interval) -1. 637x (Prodromal symptoms) -1. 773x (Retinal detachment)+1. 247. It is supposed that the Relapse Score might be helpful for predicting the clinical course and modifying the dose or duration of systemic steroid therapy of the patients with the VKH syndrome.

Citing Articles

A Case of Vogt-Koyanagi-Harada Disease: Diagnosis Based on the Presence of Vitiligo and Sunset Glow Fundus Without Ocular Symptoms.

Tsutsui H, Fukuda K, Nakajima I, Yamashiro K Cureus. 2025; 17(1):e78209.

PMID: 40026970 PMC: 11870851. DOI: 10.7759/cureus.78209.


Clinical Characteristics and Efficacy of Adalimumab and Low-Dose Methotrexate Combination Therapy in Patients With Vogt-Koyanagi-Harada Disease.

Hiyama T, Harada Y, Kiuchi Y Front Med (Lausanne). 2022; 8:730215.

PMID: 35071253 PMC: 8770852. DOI: 10.3389/fmed.2021.730215.


Mucosal-associated invariant T cells have therapeutic potential against ocular autoimmunity.

Yamana S, Shibata K, Hasegawa E, Arima M, Shimokawa S, Yawata N Mucosal Immunol. 2021; 15(2):351-361.

PMID: 34775490 DOI: 10.1038/s41385-021-00469-5.


Vogt-Koyanagi-Harada is a Curable Autoimmune Disease: Early Diagnosis and Immediate Dual Steroidal and Non-Steroidal Immunosuppression are Crucial Prerequisites.

Papasavvas I, Tugal-Tutkun I, Herbort Jr C J Curr Ophthalmol. 2021; 32(4):310-314.

PMID: 33553831 PMC: 7861101. DOI: 10.4103/JOCO.JOCO_190_20.